Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Insulin Resistance
Studies from Children's Hospital yield new information about insulin resistance in children
December 10th, 2007
Fresh data on insulin resistance are presented in the report 'Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome.' According to recent research from the United States, "Alström syndrome (AS) is an autosomal recessive disorder characterized by progressive pigmentary retinopathy, sensorineural hearing loss, fatty liver infiltration, obesity, insulin resistance and early-onset type 2 diabetes mellitus (DM2). Early onset of insulin resistance and DM2 are key components of this syndrome." "To study the effect of early initiation of the insulin sensitizer metformin combined with rosiglitazone in a patient with AS with impaired glucose tolerance....
Source: Obesity & Diabetes Week (2007-12-10)
|
